Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
617 | 13940 | 39.8 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTIPSYCHOTICS | authKW | 1046360 | 11% | 32% | 1508 |
2 | CLOZAPINE | authKW | 818544 | 7% | 38% | 995 |
3 | SCHIZOPHRENIA | authKW | 785964 | 25% | 10% | 3518 |
4 | OLANZAPINE | authKW | 747919 | 6% | 42% | 808 |
5 | RISPERIDONE | authKW | 605166 | 5% | 38% | 720 |
6 | PSYCHIATRY | WoSSC | 459810 | 65% | 2% | 9027 |
7 | ATYPICAL ANTIPSYCHOTICS | authKW | 452514 | 4% | 40% | 522 |
8 | ARIPIPRAZOLE | authKW | 353915 | 3% | 44% | 369 |
9 | ANTIPSYCHOTIC AGENTS | authKW | 234829 | 2% | 42% | 256 |
10 | ZIPRASIDONE | authKW | 231628 | 1% | 54% | 195 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 459810 | 65% | 2% | 9027 |
2 | Pharmacology & Pharmacy | 36250 | 31% | 0% | 4315 |
3 | Psychology, Clinical | 9358 | 6% | 1% | 868 |
4 | Clinical Neurology | 8763 | 12% | 0% | 1706 |
5 | Health Policy & Services | 7883 | 4% | 1% | 579 |
6 | Neurosciences | 4321 | 13% | 0% | 1756 |
7 | Nursing | 1898 | 2% | 0% | 340 |
8 | Psychology | 1376 | 3% | 0% | 369 |
9 | Medicine, General & Internal | 1208 | 6% | 0% | 840 |
10 | Public, Environmental & Occupational Health | 1075 | 5% | 0% | 698 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PSYCHIAT | 184853 | 30% | 2% | 4118 |
2 | COCHRANE IZOPHRENIA GRP | 56172 | 0% | 55% | 47 |
3 | IZOPHRENIA PROGRAM | 41134 | 1% | 21% | 89 |
4 | ZUCKER HILLSIDE HOSP | 31532 | 0% | 23% | 62 |
5 | PSYCHOSIS SERV | 29167 | 0% | 67% | 20 |
6 | ANTIPSYCHOT | 27351 | 0% | 83% | 15 |
7 | UNIV PSYCHIAT | 23442 | 1% | 11% | 98 |
8 | MED AFFAIRS EMEA | 21750 | 0% | 76% | 13 |
9 | GERIATR MENTAL HLTH PROGRAM | 21211 | 0% | 29% | 34 |
10 | EARLY PSYCHOSIS PROGRAMME | 19894 | 0% | 91% | 10 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CLINICAL PSYCHIATRY | 159613 | 5% | 10% | 720 |
2 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 94764 | 2% | 13% | 343 |
3 | JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 90999 | 2% | 18% | 230 |
4 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 80887 | 2% | 14% | 261 |
5 | SCHIZOPHRENIA RESEARCH | 66220 | 3% | 7% | 422 |
6 | PSYCHIATRIC SERVICES | 53153 | 2% | 8% | 316 |
7 | PSYCHOPHARMAKOTHERAPIE | 53111 | 1% | 22% | 110 |
8 | PHARMACOPSYCHIATRY | 44707 | 1% | 10% | 203 |
9 | SCHIZOPHRENIA BULLETIN | 33692 | 2% | 7% | 210 |
10 | INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE | 31289 | 1% | 13% | 108 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTIPSYCHOTICS | 1046360 | 11% | 32% | 1508 | Search ANTIPSYCHOTICS | Search ANTIPSYCHOTICS |
2 | CLOZAPINE | 818544 | 7% | 38% | 995 | Search CLOZAPINE | Search CLOZAPINE |
3 | SCHIZOPHRENIA | 785964 | 25% | 10% | 3518 | Search SCHIZOPHRENIA | Search SCHIZOPHRENIA |
4 | OLANZAPINE | 747919 | 6% | 42% | 808 | Search OLANZAPINE | Search OLANZAPINE |
5 | RISPERIDONE | 605166 | 5% | 38% | 720 | Search RISPERIDONE | Search RISPERIDONE |
6 | ATYPICAL ANTIPSYCHOTICS | 452514 | 4% | 40% | 522 | Search ATYPICAL+ANTIPSYCHOTICS | Search ATYPICAL+ANTIPSYCHOTICS |
7 | ARIPIPRAZOLE | 353915 | 3% | 44% | 369 | Search ARIPIPRAZOLE | Search ARIPIPRAZOLE |
8 | ANTIPSYCHOTIC AGENTS | 234829 | 2% | 42% | 256 | Search ANTIPSYCHOTIC+AGENTS | Search ANTIPSYCHOTIC+AGENTS |
9 | ZIPRASIDONE | 231628 | 1% | 54% | 195 | Search ZIPRASIDONE | Search ZIPRASIDONE |
10 | QUETIAPINE | 196032 | 2% | 31% | 285 | Search QUETIAPINE | Search QUETIAPINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HASAN, A , FALKAI, P , WOBROCK, T , LIEBERMAN, J , GLENTHOJ, B , GATTAZ, WF , THIBAUT, F , MOLLER, HJ , (2012) WORLD FEDERATION OF SOCIETIES OF BIOLOGICAL PSYCHIATRY (WFSBP) GUIDELINES FOR BIOLOGICAL TREATMENT OF SCHIZOPHRENIA, PART 1: UPDATE 2012 ON THE ACUTE TREATMENT OF SCHIZOPHRENIA AND THE MANAGEMENT OF TREATMENT RESISTANCE.WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. VOL. 13. ISSUE 5. P. 318 -378 | 381 | 77% | 86 |
2 | BAK, M , FRANSEN, A , JANSSEN, J , VAN OS, J , DRUKKER, M , (2014) ALMOST ALL ANTIPSYCHOTICS RESULT IN WEIGHT GAIN: A META-ANALYSIS.PLOS ONE. VOL. 9. ISSUE 4. P. - | 236 | 72% | 38 |
3 | BARNES, TRE , (2011) EVIDENCE-BASED GUIDELINES FOR THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: RECOMMENDATIONS FROM THE BRITISH ASSOCIATION FOR PSYCHOPHARMACOLOGY.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 25. ISSUE 5. P. 567 -620 | 323 | 54% | 109 |
4 | HASAN, A , FALKAI, P , WOBROCK, T , LIEBERMAN, J , GLENTHOJ, B , GATTAZ, WF , THIBAUT, F , MOLLER, HJ , (2013) WORLD FEDERATION OF SOCIETIES OF BIOLOGICAL PSYCHIATRY (WFSBP) GUIDELINES FOR BIOLOGICAL TREATMENT OF SCHIZOPHRENIA, PART 2: UPDATE 2012 ON THE LONG-TERM TREATMENT OF SCHIZOPHRENIA AND MANAGEMENT OF ANTIPSYCHOTIC-INDUCED SIDE EFFECTS.WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. VOL. 14. ISSUE 1. P. 2-44 | 186 | 70% | 82 |
5 | NEWCOMER, JW , (2005) SECOND-GENERATION (ATYPICAL) ANTIPSYCHOTICS AND METABOLIC EFFECTS - A COMPREHENSIVE LITERATURE REVIEW.CNS DRUGS. VOL. 19. ISSUE . P. 1 -93 | 140 | 71% | 809 |
6 | DE HERT, M , CORRELL, CU , BOBES, J , CETKOVICH-BAKMAS, M , COHEN, D , ASAI, I , DETRAUX, J , GAUTAM, S , MOLLER, HJ , NDETEI, DM , ET AL (2011) PHYSICAL ILLNESS IN PATIENTS WITH SEVERE MENTAL DISORDERS. I. PREVALENCE, IMPACT OF MEDICATIONS AND DISPARITIES IN HEALTH CARE.WORLD PSYCHIATRY. VOL. 10. ISSUE 1. P. 52 -77 | 199 | 42% | 339 |
7 | RAGGI, MA , MANDRIOLI, R , SABBIONI, C , PUCCI, V , (2004) ATYPICAL ANTIPSYCHOTICS: PHARMACOKINETICS, THERAPEUTIC DRUG MONITORING AND PHARMACOLOGICAL INTERACTIONS.CURRENT MEDICINAL CHEMISTRY. VOL. 11. ISSUE 3. P. 279-296 | 190 | 85% | 66 |
8 | GALLEGO, JA , BONETTI, J , ZHANG, JP , KANE, JM , CORRELL, CU , (2012) PREVALENCE AND CORRELATES OF ANTIPSYCHOTIC POLYPHARMACY: A SYSTEMATIC REVIEW AND META-REGRESSION OF GLOBAL AND REGIONAL TRENDS FROM THE 1970S TO 2009.SCHIZOPHRENIA RESEARCH. VOL. 138. ISSUE 1. P. 18-28 | 127 | 89% | 50 |
9 | VANCAMPFORT, D , WAMPERS, M , MITCHELL, AJ , CORRELL, CU , DE HERDT, A , PROBST, M , DE HERT, M , (2013) A META-ANALYSIS OF CARDIO-METABOLIC ABNORMALITIES IN DRUG NAIVE, FIRST-EPISODE AND MULTI-EPISODE PATIENTS WITH SCHIZOPHRENIA VERSUS GENERAL POPULATION CONTROLS.WORLD PSYCHIATRY. VOL. 12. ISSUE 3. P. 240-250 | 125 | 85% | 39 |
10 | KRUSE, G , WONG, BJO , DUH, MS , LEFEBVRE, P , LAFEUILLE, MH , FASTENAU, JM , (2015) SYSTEMATIC LITERATURE REVIEW OF THE METHODS USED TO COMPARE NEWER SECOND-GENERATION AGENTS FOR THE MANAGEMENT OF SCHIZOPHRENIA: A FOCUS ON HEALTH TECHNOLOGY ASSESSMENT.PHARMACOECONOMICS. VOL. 33. ISSUE 10. P. 1049 -1067 | 148 | 78% | 0 |
Classes with closest relation at Level 2 |